Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity.

Olsen, Lone Stengelshøj

Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity. [electronic resource] - International journal of cancer Aug 2004 - 198-205 p. digital

Publication Type: Journal Article

0020-7136

10.1002/ijc.20255 doi


Animals
Apoptosis--drug effects
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell--pathology
Cell Division
Cyanides--pharmacology
Down-Regulation
Female
Guanidines--pharmacology
Humans
I-kappa B Kinase
Lung Neoplasms--pathology
Mice
NF-kappa B--metabolism
Protein Serine-Threonine Kinases--pharmacology
Transplantation, Heterologous
Tumor Cells, Cultured